Patents by Inventor Dennis Michael Godek
Dennis Michael Godek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11426411Abstract: The invention is directed to a method of treatment for inflammation in mammals including inflammation caused by bacterial or viral infection, the method comprising administering to a mammal, including a human, in need of such treatment a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.Type: GrantFiled: August 19, 2020Date of Patent: August 30, 2022Assignee: MediSynergics, LLCInventors: Dennis Michael Godek, Harry Ralph Howard, Andrew Morgan Stewart
-
Patent number: 11007200Abstract: The invention is directed to a method of treatment for pain, the method comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.Type: GrantFiled: May 21, 2020Date of Patent: May 18, 2021Assignee: MediSynergics, LLCInventors: Dennis Michael Godek, Harry Ralph Howard, Andrew Morgan Stewart
-
Publication number: 20210060023Abstract: The invention is directed to a method of treatment for inflammation in mammals including inflammation caused by bacterial or viral infection, the method comprising administering to a mammal, including a human, in need of such treatment a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: August 19, 2020Publication date: March 4, 2021Applicant: Medisynergics, LLCInventors: Dennis Michael Godek, Harry Ralph Howard, Andrew Morgan Stewart
-
Publication number: 20210052594Abstract: The invention is directed to a method of treatment for pain, the method comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: May 21, 2020Publication date: February 25, 2021Applicant: MediSynergics, LLCInventors: Dennis Michael Godek, Harry Ralph Howard, Andrew Morgan Stewart
-
Patent number: 10351552Abstract: The invention is directed to a compound of formula I, a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing a compound of formula I, and a method of treatment of a disorder or condition in a mammal, including a human, selected from the group consisting of Human African Trypanosomiasis (HAT), Chagas disease, Leishmaniasis, toxoplasmosis and malaria.Type: GrantFiled: December 7, 2017Date of Patent: July 16, 2019Assignee: MediSynergies, LLCInventors: Harry Ralph Howard, Dennis Michael Godek, Shawn-Michael Rodriguez
-
Publication number: 20190177304Abstract: The invention is directed to a compound of formula I, a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing a compound of formula I, and a method of treatment of a disorder or condition in a mammal, including a human, selected from the group consisting of Human African Trypanosomiasis (HAT), Chagas disease, Leishmaniasis, toxoplasmosis and malaria.Type: ApplicationFiled: December 7, 2017Publication date: June 13, 2019Applicant: MediSynergics, LLCInventors: Harry Ralph Howard, Dennis Michael Godek, Shawn-Michael Rodriguez
-
Patent number: 9700563Abstract: The invention is directed to a method of treatment for chronic pain, the method comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.Type: GrantFiled: April 21, 2016Date of Patent: July 11, 2017Assignee: MediSynergies, LLCInventors: Dennis Michael Godek, Harry Ralph Howard
-
Patent number: 9517232Abstract: The invention is directed to the use of a compound of formula I, as defined herein, to a pharmaceutically acceptable salt thereof; to a pharmaceutical composition containing a compound of formula I, and to a combination of a compound of formula I with a pharmacologically effective cholinesterase inhibitor to treat a mammal, including a human, for a disorder or condition selected from the list including Alzheimer's disease, Huntington's disease, Parkinson's disease, non-Alzheimer's dementias and ALS.Type: GrantFiled: September 15, 2015Date of Patent: December 13, 2016Assignee: Medi Synergics, LLCInventors: Dennis Michael Godek, Harry Ralph Howard
-
Patent number: 9475788Abstract: The invention is directed to a compound of formula I, a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing a compound of formula I, and a method of treatment of a disorder or condition selected from the group consisting of Human African Trypanosomiasis (HAT), Chagas disease, Leishmaniasis and malaria.Type: GrantFiled: October 21, 2015Date of Patent: October 25, 2016Assignee: MediSynergics, LLCInventors: Dennis Michael Godek, Harry Ralph Howard
-
Publication number: 20160235759Abstract: The invention is directed to a method of treatment for chronic pain, the method comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: April 21, 2016Publication date: August 18, 2016Applicant: MediSynergics, LLCInventors: Dennis Michael Godek, Harry Ralph Howard
-
Publication number: 20160237052Abstract: The invention is directed to a compound of formula I, as defined herein, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition containing a compound of formula I; and a method of treatment of a disorder or condition selected from the list consisting of acute myocardial infarction; memory processes disorders; dementia; cognition disorders such as Alzheimer's disease; attention deficit disorder (ADD); attention-deficit hyperactivity disorder (ADHD); cancers such as cutaneous carcinoma, medullary thyroid carcinoma and melanoma; Meniere's disease; gastrointestinal disorders; inflammation; migraine; motion sickness; obesity; pain; septic shock; respiratory disorders (including allergic rhinitis, nasal congestion and allergic congestion) in a mammal, including a human, that may be effected by administering to said mammal a pharmacologically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.Type: ApplicationFiled: February 18, 2015Publication date: August 18, 2016Applicant: MediSynergics, LLCInventors: Dennis Michael Godek, Harry Ralph Howard
-
Patent number: 9381170Abstract: The invention is directed to the use of a compound of formula I as defined herein, a pharmaceutically acceptable salt thereof; or a pharmaceutical composition containing a compound of formula I, in treating a mammal, including a human, for a psychiatric disorder or condition selected from the group consisting of stroke, Huntington's disease and amyotrophic lateral sclerosis (ALS).Type: GrantFiled: July 28, 2015Date of Patent: July 5, 2016Assignee: MediSynergics, LLCInventors: Dennis Michael Godek, Harry Ralph Howard
-
Publication number: 20160158209Abstract: The invention is directed to the use of a compound of formula I, as defined herein, to a pharmaceutically acceptable salt thereof; to a pharmaceutical composition containing a compound of formula I, and to a combination of a compound of formula I with a pharmacologically effective cholinesterase inhibitor to treat a mammal, including a human, for a disorder or condition selected from the list including Alzheimer's disease, Huntington's disease, Parkinson's disease, non-Alzheimer's dementias and ALS.Type: ApplicationFiled: September 15, 2015Publication date: June 9, 2016Applicant: MediSynergics, LLCInventors: Dennis Michael Godek, Harry Ralph Howard
-
Publication number: 20160151308Abstract: The invention is directed to the use of a compound of formula I as defined herein, a pharmaceutically acceptable salt thereof; or a pharmaceutical composition containing a compound of formula I, in treating a mammal, including a human, for a psychiatric disorder or condition selected from the group consisting of stroke, Huntington's disease and amyotrophic lateral sclerosis (ALS).Type: ApplicationFiled: July 28, 2015Publication date: June 2, 2016Applicant: MEDISYNERGICS, LLCInventors: Dennis Michael Godek, Harry Ralph Howard
-
Patent number: 9346777Abstract: The invention is directed to a compound of formula I, as defined herein, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition containing a compound of formula I, a method of treatment of a disorder or condition that may be treated by administration of the compound, the method comprising administering to a mammal in need of such treatment a compound of formula I as described above, and a method of treatment of a disorder or condition selected from the group consisting of Human African Trypanosomiasis (HAT), Chagas disease, Leishmaniasis and malaria, the method comprising administering to a mammal, including a human, in need of such treatment a compound of formula I as described above.Type: GrantFiled: August 4, 2013Date of Patent: May 24, 2016Assignee: MediSynergics, LLCInventors: Dennis Michael Godek, Harry Ralph Howard
-
Patent number: 9345673Abstract: The invention is directed to a method of treatment of a cancer, in a mammal, the method comprising administering to said mammal in need of such treatment an effective amount of a cell growth inhibitory compound of formula I or a pharmaceutically acceptable salt form thereof.Type: GrantFiled: July 14, 2015Date of Patent: May 24, 2016Assignee: MediSynergics, LLCInventors: Dennis Michael Godek, Harry Ralph Howard
-
Publication number: 20160101068Abstract: The invention is directed to a method of treatment of a cancer, in a mammal, the method comprising administering to said mammal in need of such treatment an effective amount of a cell growth inhibitory compound of formula I or a pharmaceutically acceptable salt form thereof.Type: ApplicationFiled: July 14, 2015Publication date: April 14, 2016Applicant: MEDISYNERGICS, LLCInventors: Dennis Michael Godek, Harry Ralph Howard
-
Patent number: 9284291Abstract: The invention is directed to a compound of formula I, as defined herein, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition containing a compound of formula I, a method of treatment of a disorder or condition that may be treated by administration of the compound, the method comprising administering to a mammal in need of such treatment a compound of formula I as described above, and a method of treatment of a disorder or condition selected from the group consisting of depression, mood disorders, schizophrenia, Alzheimer's disease, anxiety and addiction, the method comprising administering to a mammal, including a human, in need of such treatment a compound of formula I as described above.Type: GrantFiled: July 29, 2014Date of Patent: March 15, 2016Assignee: MediSynergies, LLCInventors: Dennis Michael Godek, Harry Ralph Howard
-
Patent number: 9283196Abstract: The invention is directed to the use of a compound of formula I as defined herein, a pharmaceutically acceptable salt thereof; or a pharmaceutical composition containing a compound of formula I, in treating a mammal, including a human, for a psychiatric disorder or condition selected from the group consisting of depression, mood disorders, anxiety, schizophrenia, bipolar disorder (also referred to as manic-depressive disorder), addiction, cognitive impairment, Parkinson's and Alzheimer's diseases.Type: GrantFiled: July 16, 2015Date of Patent: March 15, 2016Assignee: MediSynergics, LLCInventors: Dennis Michael Godek, Harry Ralph Howard
-
Publication number: 20160039799Abstract: The invention is directed to a compound of formula I, a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing a compound of formula I, and a method of treatment of a disorder or condition selected from the group consisting of Human African Trypanosomiasis (HAT), Chagas disease, Leishmaniasis and malaria.Type: ApplicationFiled: October 21, 2015Publication date: February 11, 2016Applicant: MEDISYNERGICS, LLCInventors: Dennis Michael Godek, Harry Ralph Howard